This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Lucy Chard
10 May 2023

AI search tool helps physicians to find the perfect clinical trials for their patients

A newly developed search tool uses AI to understand patient needs and reccomend the best clinical trials for their treatment, whilst keeping physicians centered in the process to ensure the best care. 

myTomorrows, a company with a missions to connect patients, physicians and biopharma companies to reach solutions that benefit everyone, have launched a clinical trial database search tool to help patients. 

The tool, TrialSearch AI, is a physician-focused, pre-screening clinical trial search tool that uses AI technology to assist physicians in identifying clinical trials or expanded access programmes that could be beneficial for their patients. 

In normal practice, a physician will go through a patients entire medical background, and compare this to a myriad of specific clinical trial criteria – a time consuming activity. TrialSearch AI provides a much faster, more efficient way of doing this by running a side by side comparison of patient medical history and publicly available clinical trial eligibility criteria or expanded access programme criteria from programmes around the world. Once the tool has run the search, it requests that the physician complete some further manual checks, and whether a pre-approval option is applicable for particular patients. 

The tool can reduce the time physicians spend manually searching for trials by up to 90%, whilst still maintaining the layer of human decision making to give patients the best opportunity for personalised care. 

The tools should be able to help patients with unmet needs and be especially useful for those with rare diseases. 

“Our team of researchers and developers designed TrialSearch AI to bring greater speed, transparency, and accuracy to the complex, time-consuming task of manually searching for clinical trials. As a physician who cared for patients diagnosed with cancer, I know first-hand the importance of providing actionable information that can help physicians, patients, and caregivers discover and access potentially life-saving treatments,” commented Michel van Harten, CEO of myTomorrows. 

Lucy Chard
Digital Editor - Pharma

Related News